Company intelligence / Profile preview

Beijing Shipitongkang Pharmaceutical Technology

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Shibaitongkang Pharmaceutical Technology is a Chinese pharmaceutical and biotechnology company based in Beijing. The company focuses on the research, development, and technical transfer of pharmaceutical products, particularly small molecule therapeutics. One of its notable development programs includes minodronic acid tablets, a farnesyl diphosphate synthase (FDPS) inhibitor targeted for the treatment of osteoporosis, which has undergone clinical evaluation in China. Led by key personnel such as Executive Director Guojun Zheng, the company provides technical consulting and development services within the life sciences sector.

Therapeutic areas: Endocrinology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Beijing Shipitongkang Pharmaceutical Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beijing Shipitongkang Pharmaceutical Technology.

Explore the full profile